A novel, web-based, psychological intervention for people with psoriasis: The electronic Targeted Intervention for Psoriasis (eTIPs) study

British Journal of Dermatology

Volumn 169, Issue 2, 2013, Pages 329-336

  Bundy, C ^a   Pinder, B ^a   Bucci, S ^a   Reeves, D ^a   Griffiths, C E M ^a,b   Tarrier, N ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; QUALITY OF LIFE; SELF EVALUATION;

ADULT; AGED; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; TELEMEDICINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881605026     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12350     Document Type: Article

References (29)

1. Griffiths CE, Barker JN,. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
2. Fortune DG, Richards HL, Main CJ, et al,. Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psychol 2000; 5: 71-82.
3. Gupta MA, Gupta AK,. Psychiatric and psychological co-morbidity in patients with dermatological disorders: epidemiology and management. Am J Clin Dermatol 2003; 4: 833-42.
4. Richards HL, Fortune DG, Main CJ, Griffiths CEM,. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 10-15.
5. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Bowat A,. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-71.
6. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM,. The risk of depression, anxiety, and suicidality in patients with psoriasis. Arch Dermatol 2010; 146: 891-5.
7. Gupta MA, Schork NJ, Gupta AK, et al,. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-90.
8. Koo J,. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-96.
9. Ginsburg IH, Link BG,. Psychological consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993; 32: 587-91.
10. De Korte J, Sprangers MA, Mombers FM, Bos JD,. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2005; 99: 140-7.
11. Waters HC, Carter CT, Piech CT, et al,. The impact of psoriasis on psychological functioning and quality of life. J Am Acad Dermatol 2009; 60 (Suppl.): AB183.
12. Richards HL, Ray DW, Kirby B, et al,. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 2005; 153: 1114-20.
13. Chapman BP, Moynihan J,. The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol 2009; 5: 623-7.
14. Roth A, Fonagy P,. What Works for Whom? A Critical Review of Psychotherapy Research, 2nd edn. London: The Guilford Press, 2005.
15. Department of Health. Treatment Choice in Psychological Therapies and Counselling: Evidence-Based Clinical Practice Guideline. London: Stationery Office, 2001. Available at: http://www.doh. gov.uk/mentalhealth/ treatmentguideline (last accessed 8 May 2013).
16. Fortune DG, Richards HL, Main CJ, et al,. A cognitive behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002; 146: 458-65.
17. Fortune D, Richards HL, Griffiths CEM, Main CJ,. Targeting cognitive-behaviour therapy to patients' implicit models of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 2004; 43: 65-82.
18. Spek V, Nyklícek I, Cuijpers P, Pop V,. Predictors of outcome of group and internet-based cognitive behavior therapy. J Affect Disord 2008; 105: 137-45.
19. Ritterband LM, Andersson G, Christensen HM, et al,. Directions for the International Society for Research on Internet Interventions (ISRII). J Med Internet Res 2006; 8: e23.
20. Zigmond A, Snaith R,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70.
21. Feldman SR, Fleischer AB Jr, Reboussin DM, et al,. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-6.
22. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
23. Moss-Morris R, Weinman J, Petrie KJ, et al,. The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002; 17: 1-16.
24. Groenwold R, Donders A, Roes K, et al,. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol 2012; 175: 210-17.
25. Storm A, Andersen SE, Benfeldt E, Serup J,. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 2008; 59: 27-33.
26. Storm A, Andersen SE, Benfeldt E, Serup J,. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 2008; 59: 975-80.
27. Clarke G, Reid E, Eubanks D, et al,. Overcoming depression on the Internet (ODIN): a randomized controlled trial of an Internet depression skills intervention program. J Med Internet Res 2002; 4: e14.
28. Williams TL, May CR, Esmail A, et al,. Patient satisfaction with teledermatology is related to perceived quality of life. Br J Dermatol 2001; 145: 911-17.
29. Hart SL, Hart TA,. The future of cognitive behavioral interventions within behavioral medicine. J Cognitive Psychother 2010; 24: 344-54.